PLASMACYTOID; LYMPHOMA

Clinical trials for PLASMACYTOID; LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PLASMACYTOID; LYMPHOMA trials appear

Sign up with your email to follow new studies for PLASMACYTOID; LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double-Punch cell therapy aims to outsmart tough blood cancers

Disease control Recruiting now

This early-stage study is testing a new type of cell therapy designed to attack two different targets on cancer cells. It is for patients with multiple myeloma or a type of lymphoma that has come back or stopped responding to standard treatments. The main goal is to see if this t…

Matched conditions: PLASMACYTOID; LYMPHOMA

Phase: PHASE1 • Sponsor: iCell Gene Therapeutics • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

PLASMACYTOID; LYMPHOMA

Get alerted when new PLASMACYTOID; LYMPHOMA trials appear

Double-Punch cell therapy aims to outsmart tough blood cancers